anmelden
OMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.02.23 | Nokia Buy | Jefferies & Company Inc. | |
| 27.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 23.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 22.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.02.23 | AstraZeneca Neutral | UBS AG | |
| 20.02.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 20.02.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 17.02.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 16.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.02.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 15.02.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 14.02.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 14.02.23 | Nokia Outperform | Credit Suisse Group | |
| 13.02.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.02.23 | AstraZeneca Neutral | UBS AG | |
| 10.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 09.02.23 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 08.02.23 | Volvo (B) Hold | Jefferies & Company Inc. | |
| 07.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 06.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.02.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.02.23 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.23 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.02.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 02.02.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Sell | UBS AG | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
